Company intelligence / Profile preview

EVA Pharma

Ownership: Private
Development stage: Commercial

Overview

EVA Pharma is a leading pharmaceutical manufacturer in the Middle East and Africa region with a global reach, exporting to over 40 countries including the European Union. Their facilities have received approvals from various international regulatory authorities including the European Medicines Agency, Health Canada, and regional authorities in the Middle East.

Therapeutic areas: GastroenterologyPulmonologyCardiovascularPsychiatryMen's HealthMetabolic DisordersOphthalmologyEndocrinologyDermatologyOtherWomen's HealthOncologyNeurologyInfectious Diseases
Modalities: Small moleculesgenericsbranded genericsOTC medicinesherbal medicinesdietary supplementsimmunosuppressantsinsulin
Industry: Biotech

Drug pipeline

4 assets

Limitless Allzyme

3 more assets in the full pipeline.

Partnerships

Eli Lilly and Company (for insulin glargine manufacturing)Vodafone Business

Beyond the preview

Go deeper on EVA Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EVA Pharma.